| Polar substitutions in the benzenesulfonamide ring of celecoxib afford a potent 1, 5-diarylpyrazole class of COX-2 inhibitors SK Singh, PG Reddy, KS Rao, BB Lohray, P Misra, SA Rajjak, YK Rao, ... Bioorganic & medicinal chemistry letters 14 (2), 499-504, 2004 | 174 | 2004 |
| (−) 3-[4-[2-(Phenoxazin-10-yl) ethoxy] phenyl]-2-ethoxypropanoic acid [(−) DRF 2725]: a dual PPAR agonist with potent antihyperglycemic and lipid modulating activity BB Lohray, VB Lohray, AC Bajji, S Kalchar, RR Poondra, S Padakanti, ... Journal of medicinal chemistry 44 (16), 2675-2678, 2001 | 173 | 2001 |
| AMP activated protein kinase: A next generation target for total metabolic control: Oncologic, Endocrine & Metabolic P Misra Expert opinion on therapeutic targets 12 (1), 91-100, 2008 | 154 | 2008 |
| Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors SE Crawford, C Qi, P Misra, V Stellmach, MS Rao, JD Engel, Y Zhu, ... Journal of Biological Chemistry 277 (5), 3585-3592, 2002 | 146 | 2002 |
| The role of AMP kinase in diabetes P Misra, R Chakrabarti Indian Journal of Medical Research 125 (3), 389-398, 2007 | 142 | 2007 |
| Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents GR Madhavan, R Chakrabarti, SKB Kumar, P Misra, RNVS Mamidi, ... European journal of medicinal chemistry 36 (7-8), 627-637, 2001 | 117 | 2001 |
| Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP): stimulation of transcriptional regulation by mitogen … P Misra, ED Owuor, W Li, S Yu, C Qi, K Meyer, YJ Zhu, MS Rao, ... Journal of Biological Chemistry 277 (50), 48745-48754, 2002 | 106 | 2002 |
| Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid‐lowering and insulin‐sensitizing efficacy in animal models R Chakrabarti, RK Vikramadithyan, P Misra, J Hiriyan, S Raichur, ... British Journal of Pharmacology 140 (3), 527-537, 2003 | 97 | 2003 |
| Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives KA Reddy, BB Lohray, V Bhushan, AS Reddy, NVSR Mamidi, PP Reddy, ... Journal of medicinal chemistry 42 (17), 3265-3278, 1999 | 92 | 1999 |
| Synthesis and biological activity of novel pyrimidinone containing thiazolidinedione derivatives GR Madhavan, R Chakrabarti, RK Vikramadithyan, RNVS Mamidi, ... Bioorganic & medicinal chemistry 10 (8), 2671-2680, 2002 | 91 | 2002 |
| Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation P Misra, C Qi, S Yu, SH Shah, WQ Cao, MS Rao, B Thimmapaya, Y Zhu, ... Journal of Biological Chemistry 277 (22), 20011-20019, 2002 | 89 | 2002 |
| PAT5A: a partial agonist of peroxisome proliferator-activated receptor γ is a potent antidiabetic thiazolidinedione yet weakly adipogenic P Misra, R Chakrabarti, RK Vikramadithyan, G Bolusu, S Juluri, J Hiriyan, ... Journal of Pharmacology and Experimental Therapeutics 306 (2), 763-771, 2003 | 87 | 2003 |
| Ultrasound-based approach to spiro-2, 3-dihydroquinazolin-4 (1H)-ones: their in vitro evaluation against chorismate mutase D Rambabu, SK Kumar, BY Sreenivas, S Sandra, A Kandale, P Misra, ... Tetrahedron Letters 54 (6), 495-501, 2013 | 81 | 2013 |
| Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism V Kain, B Kapadia, P Misra, U Saxena Scientific reports 5 (1), 13823, 2015 | 74 | 2015 |
| Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis P Misra, JK Reddy Biochimie 98, 63-74, 2014 | 74 | 2014 |
| Synthesis and SAR/3D-QSAR studies on the COX-2 inhibitory activity of 1, 5-diarylpyrazoles to validate the modified pharmacophore SK Singh, V Saibaba, KS Rao, PG Reddy, PR Daga, SA Rajjak, P Misra, ... European journal of medicinal chemistry 40 (10), 977-990, 2005 | 60 | 2005 |
| Conformationally restricted 3, 4-diarylfuranones (2, 3a, 4, 5-tetrahydronaphthofuranones) as selective cyclooxygenase-2 inhibitors M Pal, VR Veeramaneni, M Nagabelli, SR Kalleda, P Misra, SR Casturi, ... Bioorganic & medicinal chemistry letters 13 (10), 1639-1643, 2003 | 59 | 2003 |
| Antidiabetic and hypolipidemic potential of DRF 2519—a dual activator of PPAR-α and PPAR-γ R Chakrabarti, P Misra, RK Vikramadithyan, M Premkumar, J Hiriyan, ... European journal of pharmacology 491 (2-3), 195-206, 2004 | 57 | 2004 |
| AlCl3 induced (hetero) arylation of 2, 3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents KS Kumar, D Rambabu, S Sandra, R Kapavarapu, GR Krishna, MVB Rao, ... Bioorganic & medicinal chemistry 20 (5), 1711-1722, 2012 | 55 | 2012 |
| Cu-mediated N-arylation of 1, 2, 3-triazin-4-ones: Synthesis of fused triazinone derivatives as potential inhibitors of chorismate mutase KS Kumar, R Adepu, S Sandra, D Rambabu, GR Krishna, CM Reddy, ... Bioorganic & medicinal chemistry letters 22 (2), 1146-1150, 2012 | 53 | 2012 |
